Instead, the heightened predisposition to autoreactive inflammation of HLA‐DRB1*15‐positive leukocytes may have a synergistic effect with the known pro‐inflammatory profile of the identified ECM proteins and contribute to the pathological heterogeneity observed between people with MS. Here, HLA-DRB1 is linked to myeloid sarcoma.